X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (220) 220
clinical neurology (161) 161
male (152) 152
female (145) 145
stroke (136) 136
middle aged (122) 122
aged (111) 111
peripheral vascular disease (97) 97
risk factors (74) 74
adult (55) 55
aged, 80 and over (51) 51
neurology (44) 44
treatment outcome (44) 44
prospective studies (42) 42
neurosciences (41) 41
retrospective studies (40) 40
abridged index medicus (37) 37
magnetic resonance imaging (35) 35
stroke - epidemiology (34) 34
stroke - etiology (34) 34
stroke - diagnosis (33) 33
stroke - drug therapy (33) 33
ischemia (30) 30
severity of illness index (29) 29
cohort studies (28) 28
risk (27) 27
time factors (27) 27
acute ischemic-stroke (26) 26
aspirin (26) 26
ischemic-stroke (25) 25
prognosis (25) 25
transient ischemic attack (25) 25
clinical trials (24) 24
stroke - prevention & control (24) 24
united states (24) 24
analysis (23) 23
adolescent (22) 22
cardiac & cardiovascular systems (22) 22
mortality (22) 22
prevention (22) 22
stroke - physiopathology (21) 21
brain (20) 20
fibrinolytic agents - therapeutic use (20) 20
double-blind method (19) 19
predictive value of tests (19) 19
tissue plasminogen activator - administration & dosage (19) 19
acute disease (18) 18
care and treatment (18) 18
cryptogenic stroke (18) 18
recurrence (18) 18
anticoagulants (17) 17
intracerebral hemorrhage (17) 17
medicine & public health (17) 17
medicine, general & internal (17) 17
surgery (17) 17
thrombolytic therapy (17) 17
anticoagulants - therapeutic use (16) 16
outcomes (16) 16
platelet aggregation inhibitors - therapeutic use (16) 16
research (16) 16
stenosis (16) 16
tissue plasminogen activator - therapeutic use (16) 16
trial (16) 16
young adult (16) 16
brain ischemia - drug therapy (15) 15
cerebral infarction (15) 15
infarction (15) 15
metaanalysis (15) 15
patients (15) 15
perfusion (15) 15
risk assessment (15) 15
therapy (15) 15
thrombolysis (15) 15
follow-up studies (14) 14
internal medicine (14) 14
neuroimaging (14) 14
reproducibility of results (14) 14
stroke - therapy (14) 14
tomography, x-ray computed (14) 14
atherosclerosis (13) 13
brain ischemia - diagnosis (13) 13
critical care medicine (13) 13
diagnosis (13) 13
disease (13) 13
fibrinolytic agents - administration & dosage (13) 13
management (13) 13
prevalence (13) 13
risk-factors (13) 13
safety (13) 13
subarachnoid hemorrhage (13) 13
tissue plasminogen activator - adverse effects (13) 13
animals (12) 12
atrial-fibrillation (12) 12
brain ischemia - complications (12) 12
cardiovascular (12) 12
child (12) 12
ischemic stroke (12) 12
brain ischemia - epidemiology (11) 11
cerebral blood flow (11) 11
cerebrovascular circulation (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 23, pp. 2191 - 2201
In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a... 
CRYPTOGENIC STROKE | TRIALS | MEDICINE, GENERAL & INTERNAL | DESIGN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | ANTITHROMBOTIC THERAPY | FORAMEN OVALE CLOSURE | ATRIAL-FIBRILLATION | Stroke - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Brain Ischemia - prevention & control | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Embolism - drug therapy | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Prevention | Rivaroxaban | Complications and side effects | Dosage and administration | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Neurosciences | Embolisms | Stenosis | Bleeding | Design | Ischemia | Atherosclerosis | Drug dosages | Research centers | Anticoagulants | Medical research | Stroke | Aspirin | Internal medicine | Research & development--R&D | Thrombosis | Patients | Embolism | Blood clots | Medicine | Neurology | Hospitals | Life Sciences | Human health and pathology | metaanalysis | atrial-fibrillation | foramen ovale closure | antithrombotic therapy | Klinisk medicin | efficacy | warfarin | Clinical Medicine | trials | safety | design | cryptogenic stroke | General & Internal Medicine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 11, pp. 1033 - 1042
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 8, pp. 708 - 718
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 24, pp. 2295 - 2306
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 24, pp. 2283 - 2293
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 26, pp. 2457 - 2466
Journal Article
Lancet neurology, ISSN 1474-4422, 2017, Volume 16, Issue 4, pp. 301 - 310
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 10, pp. 911 - 920
Journal Article